Doxorubicin Active Not Recruiting Phase 2 Trials for Hodgkins Disease (HD) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02181738Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)
NCT01858922Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A